The effect of a CRF preparation on ACTH release in rats bearing hypothalamic dexamethasone implants: a study on the "implantation paradox".
D000324:Adrenocorticotropic Hormone / Q000378:metabolism*; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D002217:Carbachol / Q000494:pharmacology; D003346:Corticotropin-Releasing Hormone / Q000096:biosynthesis / Q000494:pharmacology*; D003907:Dexamethasone / Q000494:pharmacology*; D004837:Epinephrine / Q000494:pharmacology; D005246:Feedback; D005260:Female; D006632:Histamine / Q000494:pharmacology; D007031:Hypothalamus / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D010902:Pituitary Gland; D010913:Pituitary-Adrenal System / Q000187:drug effects; D011453:Prostaglandins / Q000494:pharmacology; D051381:Rats; D013312:Stress, Physiological; D014020:Tissue Extracts / Q000494:pharmacology; D014667:Vasopressins / Q000494:pharmacology
D011453:Prostaglandins; D014020:Tissue Extracts; D014667:Vasopressins; D000804:Angiotensin II; D003907:Dexamethasone; D006632:Histamine; D002217:Carbachol; D000324:Adrenocorticotropic Hormone; D003346:Corticotropin-Releasing Hormone; D004837:Epinephrine